percentage decrease in volume. Launched stage 2023 and 2024 by development stage. Where deals of development for different indications, the highest in deals (65%). These were mainly focused on single has been selected for the analysis, irrespective of the 7% from 2024 to 2025, while the level of licensing remained muted in 2025, with deals involving assets